Next Article in Journal
Diagnosed but Not Undiagnosed Diabetes Is Associated with Depression in Rural Areas
Previous Article in Journal
The Association between Alcohol Consumption and β-Cell Function and Insulin Sensitivity in Korean Population
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Association between Endometriosis, Tubal Ligation, Hysterectomy and Epithelial Ovarian Cancer: Meta-Analyses

1
School of Mathematics and Statistics, Northeast Normal University, Changchun 130024, China
2
Epidemiology and Statistics, School of Public Health, Jilin University, Changchun 130021, China
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2016, 13(11), 1138; https://doi.org/10.3390/ijerph13111138
Submission received: 3 July 2016 / Revised: 2 November 2016 / Accepted: 10 November 2016 / Published: 14 November 2016

Abstract

:
To investigate the association between endometriosis, tubal ligation, hysterectomy and epithelial ovarian cancer. Relevant published literatures were searched in PubMed, ProQuest, Web of Science and Medline databases during 1995–2016. Heterogeneity was evaluated by I2 statistic. Publication bias was tested by funnel plot and Egger’s test. Odds ratio and 95% CI were used to assess the association strength. The statistical analyses in this study were accomplished by STATA software package. A total of 40,609 cases of epithelial ovarian cancer and 368,452 controls in 38 publications were included. The result suggested that endometriosis was associated with an increased risk of epithelial ovarian cancer (OR = 1.42, 95% CI = 1.28–1.57), tubal ligation was associated with a decreased risk of epithelial ovarian cancer (OR = 0.70, 95% CI = 0.60–0.81), while hysterectomy show no relationship with epithelial ovarian cancer (OR = 0.97, 95% CI = 0.81–1.14). A stratified analysis showed there were associations between endometriosis and the increased risk of epithelial ovarian cancer for studies conducted in USA and Europe. Meanwhile, there were associations between tubal ligation and the decreased risk of epithelial ovarian cancer for studies conducted in USA, Asia, Europe and Australia. The result indicated that endometriosis was a risk factor of epithelial ovarian cancer whereas tubal ligation was a protective risk factor of epithelial ovarian cancer, hysterectomy may have no relationship with epithelial ovarian cancer.

1. Introduction

Epithelial ovarian cancer (EOC) is the fifth leading cause of cancer death and the eighth most common cancer in women [1,2]. Approximately 1 in 70 women in the United States bear the pain of EOC, and the annual fatality rate of EOC cases is about 50% [3]. Clinical and epidemiologic studies have shown that the early detection technology of EOC is not yet perfect, and EOC is often diagnosed at advanced stage. In addition, overall five-year survival rate of EOC is about 45% [4]. Thus, the exploration of risk factors is imperative for the reduction of the burden of disease.
Recently, certain modifiable risk factors have been reported to be related to EOC. Ness et al. demonstrated that endometriosis was a risk factor of EOC [5]. However, in some studies, endometriosis may be not a risk factor of EOC [6,7]. Several years ago, most studies have proved that hysterectomy with conservation of at least one ovary could decrease the risk of developing EOC by 20%–40% [8]. However, recent studies have reported that hysterectomy was a risk factor of EOC. Tubal ligation is also associated with a 30% decreased risk of EOC incidence [9,10].
Although many researches about the associations of endometriosis, hysterectomy, tubal ligation and EOC based on individual-patients or pooled analyses based on published studies have already been conducted, such as Pearce et al. 2012 on endometriosis, Jordan et al. 2013 on hysterectomy, and Cibula et al. 2011 on tubal ligation [8,10,11], several years past, new studies were published, so, in our study, we re-researched the individual-patients studies and included several new studies after 2013 which added 14,424 cases and 265,720 controls [6,7,12,13,14], and then conducted an updated meta-analysis which further explore and confirm whether endometriosis, hysterectomy, tubal ligation are associated with EOC. In our study, 38 case-control publications from 1988 to 2016 have been brought together, checked, and analyzed centrally.

2. Methods

2.1. Literature Search

The medical literature electronic databases of PubMed, ProQuest, Web of Science (SCI) and Medline were searched for case-control studies which were related to risk factors of EOC and published prior to September 2016. The terms (endometriosis and epithelial ovarian cancer); (hysterectomy and epithelial ovarian cancer); (tubal ligation and epithelial ovarian cancer) and (endometriosis or hysterectomy or tubal ligation and epithelial ovarian cancer) of search strategy were used. In addition, references of each included studies were manually searched to identify any additional studies that were not indexed by the electronic database.

2.2. Study Selection

The following inclusion criteria were used in selecting case-control studies: (1) studies in which a case-control study design were used and investigated the association between endometriosis or hysterectomy or tubal ligation and EOC; (2) cases consisted of women who were histological diagnosed EOC; (3) the data of case and control numbers in different risk factors were presented in the publication or the data given were necessary to calculate these; (4) Odds ratio (OR) or OR with 95% confidence intervals (CIs) of each risk factor were presented in the publication or the data given were necessary to calculate these; (5) when the publications were from the same or overlapping data, we selected the most recent or largest population; (6) English was stipulated as the publication language; (7) reviews, letters or case reports were excluded.

2.3. Data Extraction

According to the predefined selection criteria, the data in whole process was independently extracted from each study by two reviewers. When disagreements appeared, the reviewers reanalyzed the study and resolved disagreements by discussion. For each study, we recorded number of case and control, the first author’s name, year of diagnosis, year of publication, study geographic region, confounders and study type as the basic contents of the data extraction. If the number of case and control in different risk factors were available, we abstracted directly, or we calculated via raw data given in the articles.

2.4. Quality Assessment

We evaluated the quality of individual studies using the Newcastle-Ottawa Scale (NOS) [15]. The NOS consists of three broad perspectives of quality: the selection, compare ability and exposure of each case-control study. The NOS assigned a maximum of four points for selection, two points for comparability and three points for exposure [16]. In this study, we considered a study with a total of seven points or greater as a high-quality study. In this meta-analysis, of all case-control studies involved, 36 (95%) were of high quality with an average NOS score of 7.4. Any disagreements were resolved by discussion and re-evaluation of the methodology of the study with a third reviewer.

2.5. Statistical Analysis

All statistical analyses in this study were performed with STATA software package (version 12.0, StataCorp., College Station, TX, USA). OR and OR with 95% CI were used as measures of the association strength. We evaluated the degree of heterogeneity in eligible studies by using I2 statistic. If p < 0.10, statistically significant heterogeneity was indicated, then random-effect models were conducted for the heterogeneous data. Otherwise, fixed effects model were used. Publication bias was evaluated via funnel plot and Egger’s test, with p < 0.05 indicating statistical significance. Subgroup analyses were conducted based on area. A cumulative meta-analysis was conducted to reflect a framework for the dynamic change trend for the results of the study and measure the effect of each research as evidence accumulates and find the trend in estimated risk effect [17]. In this meta-analysis, studies were estimated by year of publication.

3. Results

3.1. Search Results and Study Characteristics

As shown in Figure 1, we identified 12 studies [5,6,7,11,14,18,19,20,21,22,23,24] for the examination of endometriosis and epithelial ovarian cancer, 22 studies [11,12,14,18,19,22,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39] for the examination of hysterectomy and epithelial ovarian cancer, 25 studies [6,7,9,11,13,14,18,19,21,24,30,31,33,34,37,38,39,40,41,42,43,44,45,46,47] for the examination of tubal ligation and epithelial ovarian cancer. A total of 38 eligible case-control publications during the period 1988 and 2016 were identified in this meta-analysis. The main characteristics of the eligible 38 publications were listed in Table 1. All included studies were composed of 40,609 cases of ovarian cancer and 368,452 controls, the age range of all subjects was from 20 to 74 years old. The 38 publications were done in 11 countries altogether, mainly in North America, Europe, Oceania and Asia. Although there were several large prospective (cohort) studies that have published to show the association between endometriosis, tubal ligation, hysterectomy and epithelial ovarian cancer [13,48,49,50], for consistency we chose to restrict our analysis to results from case-control studies.

3.2. Quantitative Synthesis

All analyses of each risk factor were based on the random-effects model (for endometriosis, p of heterogeneity was ˂0.001; for hysterectomy, p of heterogeneity was ˂0.001; for tubal ligation, p of heterogeneity was ˂0.001). High heterogeneity were found among the included studies of each risk factor. Considered that the 38 publications we included were mainly done in North America, Europe, Oceania and Asia, and we wanted to compare the different association among these areas, so we conducted a subgroup analysis based on area. Table 2 displayed the number of subjects and ORs with 95% CI for endometriosis, hysterectomy, tubal ligation and ovarian cancer in different areas.
A statistical-significant association was found between endometriosis and EOC (OR = 1.42, 95% CI = 1.28–1.57). For area, there were associations between endometriosis and the increased risk of ovarian cancer for North America (OR = 1.42, 95% CI = 1.27–1.60), Europe (OR = 1.28, 95% CI = 1.12–1.47) and Oceania (OR = 2.52, 95% CI = 1.63–3.90) (forest plots of subgroup analysis are shown in supplement Figure S1).
No statistical association was found between hysterectomy and EOC risk (OR = 0.97, 95% CI = 0.81–1.14). For area, there were no associations between hysterectomy and EOC for North America (OR = 1.00, 95% CI = 0.93–1.09), Europe (OR = 0.97, 95% CI = 0.86–1.10) and Oceania (OR = 0.98, 95% CI = 0.79–1.21).
There was a significant association between tubal ligation and a decreased risk of EOC (OR = 0.70, 95% CI = 0.60–0.781). For area, tubal ligation was associated with a decreased risk of EOC for North America (OR = 0.68, 95% CI = 0.64–0.72), Oceania (OR = 0.48, 95% CI = 0.39–0.60) and Europe (OR = 0.82, 95% CI = 0.75–0.89). But there was no association between tubal ligation and EOC for Asia (OR = 0.85, 95% CI = 0.58–1.24).

3.3. Bias Diagnosis

Funnel plots and Begg’s test were used to assess publication bias. The result of funnel plots for each risk factor suggested no obvious asymmetry (The figures were shown in supplement Figure S2). Then the Egger’s test was used to confirm the results (for endometriosis: p = 0.242; for hysterectomy: p = 0.314; for tubal ligation: p = 0.757). Neither funnel plots nor Egger’s test suggested any obvious evidence of publication bias (Figure 2).

3.4. Sensitivity Analysis

In the sensitivity analysis, when all studies was removed one by one and the rest were analyzed sequentially by meta-analysis, the pooled ORs were not materially altered with the overall pooled ORs, indicating our results were statistically robust (shown in Supplementary Materials Figure S3).

3.5. Cumulative Meta-Analysis

In cumulative meta-analysis, the estimates gradually became consistent, a more significant association between the three factors and risk of EOC was observed as evidence accumulated by publication year (shown in Supplementary Materials Figure S4).

4. Discussion

According to the inclusive papers, which included 40,609 cases of epithelial ovarian cancer and 368,452 controls, we found that endometriosis was a risk factor of epithelial ovarian cancer whereas tubal ligation was a protective risk factor of epithelial ovarian cancer, hysterectomy may had no relationship with epithelial ovarian cancer.
The previous meta-analysis have reported that endometriosis is conformed to be a risk factor of EOC. Pearce CL et al. reported that endometriosis was associated with a significantly increased risk of clear cell (OR = 3.05, 95% CI = 2.43–3.84) and endometrioid invasive ovarian cancers (OR = 2.04, 95% CI = 1.67–2.48) [11]. The combined outcomes in this meta-analysis suggested that endometriosis was a risk factor of EOC (OR = 1.42, 95% CI = 1.28–1.57), which was consistent with the above-mentioned reports. In the study of Pearce et al., the data was also extracted from case-control studies, but the standard of subgroup analyses and confounding factor were different from our study. Although the data sources and the object of the above study was different from our study, we got the same conclusion, confirming that endometriosis is a quite possibly risk factor of EOC. Endometriosis is a common gynecological diseases, which can leads to dysmenorrhea, pelvic inflammation, adhesions and infertility [51]. The pathological features of endometriosis are ectopic growth of endometrial glands and stroma and the growth of endometrial tissue is oestrogen dependent [52]. Recent researches reviewed the mechanisms of endometriosis in EOC mainly in three ways. One was an oestrogen-dependent way. Ness et al. reported that endometriosis was a precursor for EOC and was more easier developed to EOC in the condition of low- progesterone and high-oestrogen [51]. The second way was genetic mutations in endometriosis tissues, such as hepatocyte nuclear factor-1β (HNF-1β) [53] and ARID1A [12]. Moreover, chronic inflammation, heme or free iron-induced oxidative stress in endometriosis tissues also reported related to EOC [13].
As for the other risk factor, hysterectomy, Jordan et al. found that hysterectomy decreased the risk of EOC (OR = 0.81; 95% CI = 0.72–0.92) [8]. However, the outcomes in this meta-analysis hysterectomy show no relationship with epithelial ovarian cancer (OR = 0.97, 95% CI = 0.81–1.14), which was not consistent with the results of Jordan. The reasons of the controversial results include study design of eligible studies, the number of objects in each study, adjustment of confounding factors and the quality of study. In the study of Jordan et al., five cohort studies, 13 case-control studies, one nested case-control study and one pooled analysis of case-control studies were included, whereas, 22 case-control publications of high quality were eligible in this meta-analysis. Furthermore, the previous pooled analysis reported cases diagnosed during 1971–2005, whereas our study was during 1988–2016, we use the newest data available that made the results more persuasive. The result that hysterectomy was associated with a risk of EOC in some studies is reasonable when considered that the most commonly hormone replacement therapy (HRT) of women had a hysterectomy is prescribed oestrogen without a progestin and oestrogen-only HRT could increase the risk of EOC [14].
Cibula et al. [10] found that tubal ligation reduced the risk of EOC by 34% (OR = 0.66, 95% CI = 0.60–0.73). The outcomes in this meta-analysis suggested that tubal ligation was a protective factor of EOC (OR = 0.70, 95% CI = 0.60–0.78), which was consistent with the results of studies above. In the studies of Cibula et al., the data were extract from cohort studies and case-control studies, standard of subgroup analyses and confounding factor were different from our study, most objects were from Asian or the USA. Although their data sources are different from our study, we get the same conclusion, which further confirmed that tubal ligation is a quite possibly protective factor of OC. Tubal ligation may form a mechanical barrier to cut down the retrograde transport of cancerogenic substances via the perineum and vagina [14,54]. The carcinogenic mechanism above provide theoretical support for our research results.
In our study, we used Stata. 12.0 to analyze the data extracted from 38 articles. The results showed that there was high heterogeneity among the included studies. To explore the source of the heterogeneity, we wanted to conduct subgroup analysis based on histological type, as studies showed that showed that the association between endometriosis and EOC risk varied significantly by histologic type [10,41], however, data was limited, we could not extract enough data to conduct an effective meta-analysis. Then, we conducted a subgroup analysis based on area, for the reason that the 38 included publications are mainly conducted in North America, Europe, Oceania and Asia and we wanted to compare the differences among the four areas. The results showed that the subgroup analysis about the association between the three factors and EOC based on area were all the same with the overall results except the Asia group for the association between tubal ligation and EOC (OR = 0.85, 95% CI = 0.58, 1.24), indicating that there was no association between tubal ligation and EOC for Asia.
However, this meta-analysis still has several limitations. Firstly, only those papers written in English were included, relevant articles using other languages had not been enrolled in, leading information loss. Secondly, all studies we searched were published articles, as a result, unpublished data were not available, some useful information may be lost with much possible, what’s more, Deeks’ funnel plot asymmetry test showed that no significant publication bias among the studies, but the bias caused by those unpublished data should not be completely ignored. Thirdly, despite of the strict inclusive criteria, significant heterogeneity was still detected among different studies, we are clear that the association between endometriosis, hysterectomy, tubal ligation and EOC varied significantly, but we couldn’t conduct a subgroup analysis because histological data were limited. Only several studies among the included articles did histology analysis, so we could not extract enough data to conduct an effective meta-analysis.

5. Conclusions

The results showed that endometriosis was a risk factor of epithelial ovarian cancer whereas tubal ligation was associated with a reduced risk of epithelial ovarian cancer, hysterectomy may had no relationship with epithelial ovarian cancer.

Supplementary Materials

The following are available online at www.mdpi.com/1660-4601/13/11/1138/s1. Figure S1: (A) The subgroup-analysis forest plot for the association between endometriosis and EOC; (B) The subgroup-analysis forest plot for the association between hysterectomy and EOC; (C) The subgroup-analysis forest plot for the association between tubal ligation and EOC, Figure S2: (A) The funnel plot for the association between endometriosis and EOC; (B) The funnel plot for the association between hysterectomy and EOC; (C) The funnel plot for the association between tubal ligation and EOC, Figure S3. (A) The sensitivity analysis plot for the association between endometriosis and EOC; (B) The sensitivity analysis plot for the association between hysterectomy and EOC; (C) The sensitivity analysis plot for the association between tubal ligation and EOC, Figure S4. (A) The cumulative analysis plot for the association between endometriosis and EOC; (B) The cumulative analysis plot for the association between hysterectomy and EOC; (C) The cumulative analysis plot for the association between tubal ligation and EOC.

Acknowledgments

This work was supported by the project is supported by Youth Research Fund Project of Medical Research Support Program of Norman Bethune Health Science Center of Jilin University (2013202013), Postdoctoral Scientific Research Project of Jilin Province (RB201343) and Jilin University and Science and Technology Project of the Department of Health of Jilin Province (2013Z034).

Author Contributions

Chunpeng Wang was involved in literature searching, data extraction and writing of manuscript. Xin Liu was involved in design and revise of manuscript. Qian Zhang, Zhenzhen Liang and Shuang Li were involved in data extraction, statistical analysis.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Ferlay, J.; Shin, H.R.; Bray, F.; Forman, D.; Mathers, C.; Parkin, D.M. Estimates of worldwide burden of cancer in 2008: Globocan 2008. Int. J. Cancer 2010, 127, 2893–2917. [Google Scholar] [CrossRef] [PubMed]
  2. Jemal, A.; Bray, F.; Center, M.M.; Ferlay, J.; Ward, E.; Forman, D. Global cancer statistics. CA Cancer J. Clin. 2011, 61, 69–90. [Google Scholar] [CrossRef] [PubMed]
  3. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Thun, M.J. Cancer statistics, 2009. CA Cancer J. Clin. 2009, 59, 225–249. [Google Scholar] [CrossRef] [PubMed]
  4. Siegel, R.; Naishadham, D.; Jemal, A. Cancer statistics, 2012. CA Cancer J. Clin. 2012, 62, 10–29. [Google Scholar] [CrossRef] [PubMed]
  5. Ness, R.B.; Grisso, J.A.; Cottreau, C.; Klapper, J.; Vergona, R.; Wheeler, J.E.; Morgan, M.; Schlesselman, J.J. Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer. Epidemiology 2000, 11, 111–117. [Google Scholar] [CrossRef] [PubMed]
  6. Madsen, C.; Baandrup, L.; Dehlendorff, C.; Kjaer, S.K. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: A nationwide case-control study. Acta Obstet. Gynecol. Scand. 2015, 94, 86–94. [Google Scholar] [CrossRef] [PubMed]
  7. Lessard-Anderson, C.R.; Handlogten, K.S.; Molitor, R.J.; Dowdy, S.C.; Cliby, W.A.; Weaver, A.L.; Sauver, J.S.; Bakkum-Gamez, J.N. Effect of tubal sterilization technique on risk of serous epithelial ovarian and primary peritoneal carcinoma. Gynecol. Oncol. 2014, 135, 423–427. [Google Scholar] [CrossRef] [PubMed]
  8. Jordan, S.J.; Nagle, C.M.; Coory, M.D.; Maresco, D.; Protani, M.M.; Pandeya, N.A.; Balasubramaniam, K.D.; Webb, P.M. Has the association between hysterectomy and ovarian cancer changed over time? A systematic review and meta-analysis. Eur. J. Cancer 2013, 49, 3638–3647. [Google Scholar] [CrossRef] [PubMed]
  9. Pike, M.C.; Pearce, C.L.; Peters, R.; Cozen, W.; Wan, P.; Wu, A.H. Hormonal factors and the risk of invasive ovarian cancer: A population-based case-control study. Fertil. Steril. 2004, 82, 186–195. [Google Scholar] [CrossRef] [PubMed]
  10. Cibula, D.; Widschwendter, M.; Majek, O.; Dusek, L. Tubal ligation and the risk of ovarian cancer: Review and meta-analysis. Hum. Reprod. Update 2011, 17, 55–67. [Google Scholar] [CrossRef] [PubMed]
  11. Pearce, C.L.; Templeman, C.; Rossing, M.A.; Lee, A.; Near, A.M.; Webb, P.M.; Nagle, C.M.; Doherty, J.A.; Cushing-Haugen, K.L.; Wicklund, K.G.; et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: A pooled analysis of case-control studies. Lancet. Oncol. 2012, 13, 385–394. [Google Scholar] [CrossRef]
  12. Le, N.D.; Leung, A.; Brooks-Wilson, A.; Gallagher, R.P.; Swenerton, K.D.; Demers, P.A.; Cook, L.S. Occupational exposure and ovarian cancer risk. Cancer Causes Control 2014, 25, 829–841. [Google Scholar] [CrossRef] [PubMed]
  13. Huang, Z.; Gao, Y.; Wen, W.; Li, H.; Zheng, W.; Shu, X.O.; Beeghly-Fadiel, A. Contraceptive methods and ovarian cancer risk among Chinese women: A report from the Shanghai Women’s Health Study. Int. J. Cancer 2015, 137, 607–614. [Google Scholar] [CrossRef] [PubMed]
  14. Ruiz, M.P.; Morales-Ramirez, P.B.; Dziadek, O.L.; Algren, S.D. Epithelial ovarian cancer and type of peritoneal insult: A case-control study. Eur. J. Obstet. Gynecol. Reprod. Biol. 2016, 205, 170–173. [Google Scholar] [CrossRef] [PubMed]
  15. Lo, C.K.; Mertz, D.; Loeb, M. Newcastle-Ottawa scale: Comparing reviewers’ to authors’ assessments. BMC Med. Res. Methodol. 2014, 14, 45. [Google Scholar] [CrossRef] [PubMed]
  16. Stang, A. Critical evaluation of the newcastle-ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 2010, 25, 603–605. [Google Scholar] [CrossRef] [PubMed]
  17. Lau, J.; Antman, E.M.; Jimenez-Silva, J.; Kupelnick, B.; Mosteller, F.; Chalmers, T.C. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N. Engl. J. Med. 1992, 327, 248–254. [Google Scholar] [CrossRef] [PubMed]
  18. Modugno, F.; Ness, R.B.; Allen, G.O.; Schildkraut, J.M.; Davis, F.G.; Goodman, M.T. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis. Am. J. Obstet. Gynecol. 2004, 191, 733–740. [Google Scholar] [CrossRef] [PubMed]
  19. Nagle, C.M.; Olsen, C.M.; Webb, P.M.; Jordan, S.J.; Whiteman, D.C.; Green, A.C.; Australian Ovarian Cancer Study Group. Endometrioid and clear cell ovarian cancers: A comparative analysis of risk factors. Eur. J. Cancer 2008, 44, 2477–2484. [Google Scholar] [CrossRef] [PubMed]
  20. Rossing, M.A.; Cushing-Haugen, K.L.; Wicklund, K.G.; Doherty, J.A.; Weiss, N.S. Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery. Cancer Causes Control 2008, 19, 1357–1364. [Google Scholar] [CrossRef] [PubMed]
  21. Wu, A.H.; Pearce, C.L.; Tseng, C.C.; Templeman, C.; Pike, M.C. Markers of inflammation and risk of ovarian cancer in Los Angeles County. Int. J. Cancer 2009, 124, 1409–1415. [Google Scholar] [CrossRef] [PubMed]
  22. Moorman, P.G.; Palmieri, R.T.; Akushevich, L.; Berchuck, A.; Schildkraut, J.M. Ovarian cancer risk factors in African-American and white women. Am. J. Epidemiol. 2009, 170, 598–606. [Google Scholar] [CrossRef] [PubMed]
  23. Bodmer, M.; Becker, C.; Meier, C.; Jick, S.; Meier, C. Use of metformin and the risk of ovarian cancer: A case-control analysis. Gynecol. Oncol. 2011, 123, 200–204. [Google Scholar] [CrossRef] [PubMed]
  24. Merritt, M.A.; de Pari, M.; Vitonis, A.F.; Titus, L.J.; Cramer, D.W.; Terry, K.L. Reproductive characteristics in relation to ovarian cancer risk by histologic pathways. Hum. Reprod. 2013, 28, 1406–1417. [Google Scholar] [CrossRef] [PubMed]
  25. Whittemore, A.S.; Wu, M.L.; Paffenbarger, R.S., Jr.; Sarles, D.L.; Kampert, J.B.; Grosser, S.; Jung, D.L.; Ballon, S.; Hendrickson, M. Personal and environmental characteristics related to epithelial ovarian cancer. II. Exposures to talcum powder, tobacco, alcohol, and coffee. Am. J. Epidemiol. 1988, 128, 1228–1240. [Google Scholar] [PubMed]
  26. Hartge, P.; Hoover, R.; Mcgowan, L.; Lesher, L.; Norris, H.J. Menopause and ovarian cancer. Am. J. Epidemiol. 1988, 127, 990–998. [Google Scholar] [PubMed]
  27. Booth, M.; Beral, V.; Smith, P. Risk factors for ovarian cancer: A case-control study. Br. J. Cancer 1989, 60, 592–598. [Google Scholar] [CrossRef] [PubMed]
  28. Irwin, K.L.; Weiss, N.S.; Lee, N.C.; Peterson, H.B. Tubal sterilization, hysterectomy, and the subsequent occurrence of epithelial ovarian cancer. Am. J. Epidemiol. 1991, 134, 362–369. [Google Scholar] [PubMed]
  29. Parazzini, F.; Negri, E.; La Vecchia, C.; Luchini, L.; Mezzopane, R. Hysterectomy, oophorectomy, and subsequent ovarian cancer risk. Obstet. Gynecol. 1993, 81, 363–366. [Google Scholar] [PubMed]
  30. Cramer, D.W.; Xu, H. Epidemiologic evidence for uterine growth factors in the pathogenesis of ovarian cancer. Ann. Epidemiol. 1995, 5, 310–314. [Google Scholar] [CrossRef]
  31. Rosenblatt, K.A.; Thomas, D.B. Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The world health organization collaborative study of neoplasia and steroid contraceptives. Cancer Epidemiol. Biomark. Prev. 1996, 5, 933–935. [Google Scholar]
  32. Green, A.; Purdie, D.; Bain, C.; Siskind, V.; Russell, P.; Quinn, M.; Ward, B. Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer. Survey of Women’s Health Study Group. Int. J. Cancer 1997, 71, 948–951. [Google Scholar]
  33. Wittenberg, J.; Cook, L.S.; Rossing, M.A.; Weiss, N.S. Reproductive risk factors for mucinous and non-mucinous epithelial ovarian cancer. Epidemiology 1999, 10, 761–763. [Google Scholar] [CrossRef] [PubMed]
  34. Riman, T.; Dickman, P.W.; Nilsson, S.; Correia, N.; Nordlinder, H.; Magnusson, C.M.; Persson, I.R. Risk factors for invasive epithelial ovarian cancer: Results from a Swedish case-control study. Am. J. Epidemiol. 2002, 156, 363–373. [Google Scholar] [CrossRef] [PubMed]
  35. Chiaffarino, F.; Parazzini, F.; Decarli, A.; Franceschi, S.; Talamini, R.; Montella, M.; La Vecchia, C. Hysterectomy with or without unilateral oophorectomy and risk of ovarian cancer. Gynecol. Oncol. 2005, 97, 318–322. [Google Scholar] [CrossRef] [PubMed]
  36. Mills, P.K.; Riordan, D.G.; Cress, R.D.; Goldsmith, D.F. Hormone replacement therapy and invasive and borderline epithelial ovarian cancer risk. Cancer Detect. Prev. 2005, 29, 124–132. [Google Scholar] [CrossRef] [PubMed]
  37. Risch, H.A.; Bale, A.E.; Beck, P.A.; Zheng, W. Pgr +331 A/G and increased risk of epithelial ovarian cancer. Cancer Epidemiol. Biomark. Prev. 2006, 15, 1738–1741. [Google Scholar] [CrossRef] [PubMed]
  38. Faber, M.T.; Jensen, A.; Frederiksen, K.; Glud, E.; Hogdall, E.; Hogdall, C.; Blaakaer, J.; Kjaer, S.K. Oral contraceptive use and impact of cumulative intake of estrogen and progestin on risk of ovarian cancer. Cancer Causes Control 2013, 24, 2197–2206. [Google Scholar] [CrossRef] [PubMed]
  39. Rice, M.S.; Murphy, M.A.; Vitonis, A.F.; Cramer, D.W.; Titus, L.J.; Tworoger, S.S.; Terry, K.L. Tubal ligation, hysterectomy and epithelial ovarian cancer in the new england case-control study. Int. J. Cancer 2013, 133, 2415–2421. [Google Scholar] [CrossRef] [PubMed]
  40. Mori, M.; Miyake, H. Dietary and other risk factors of ovarian cancer among elderly women. Jpn. J. Cancer Res. 1988, 79, 997–1004. [Google Scholar] [CrossRef] [PubMed]
  41. Purdie, D.; Green, A.; Bain, C.; Siskind, V.; Ward, B.; Hacker, N.; Quinn, M.; Wright, G.; Russell, P.; Susil, B. Reproductive and other factors and risk of epithelial ovarian cancer: An Australian case-control study. Survey of Women’s Health Study Group. Int. J. Cancer 1995, 62, 678–684. [Google Scholar] [CrossRef] [PubMed]
  42. Narod, S.A.; Sun, P.; Ghadirian, P.; Lynch, H.; Isaacs, C.; Garber, J.; Weber, B.; Karlan, B.; Fishman, D.; Rosen, B.; et al. Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: A case-control study. Lancet 2001, 357, 1467–1470. [Google Scholar] [CrossRef]
  43. Mills, P.K.; Riordan, D.G.; Cress, R.D. Epithelial ovarian cancer risk by invasiveness and cell type in the central valley of California. Gynecol. Oncol. 2004, 95, 215–225. [Google Scholar] [CrossRef] [PubMed]
  44. McGuire, V.; Felberg, A.; Mills, M.; Ostrow, K.L.; DiCioccio, R.; John, E.M.; West, D.W.; Whittemore, A.S. Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations. Am. J. Epidemiol. 2004, 160, 613–618. [Google Scholar] [CrossRef] [PubMed]
  45. Moorman, P.G.; Calingaert, B.; Palmieri, R.T.; Iversen, E.S.; Bentley, R.C.; Halabi, S.; Berchuck, A.; Schildkraut, J.M. Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women. Am. J. Epidemiol. 2008, 167, 1059–1069. [Google Scholar] [CrossRef] [PubMed]
  46. Grant, D.J.; Moorman, P.G.; Akushevich, L.; Palmieri, R.T.; Bentley, R.C.; Schildkraut, J.M. Primary peritoneal and ovarian cancers: An epidemiological comparative analysis. Cancer Causes Control 2010, 21, 991–998. [Google Scholar] [CrossRef] [PubMed]
  47. Vitonis, A.F.; Titus-Ernstoff, L.; Cramer, D.W. Assessing ovarian cancer risk when considering elective oophorectomy at the time of hysterectomy. Obstet. Gynecol. 2011, 117, 1042–1050. [Google Scholar] [CrossRef] [PubMed]
  48. Rice, M.S.; Hankinson, S.E.; Tworoger, S.S. Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses’ Health Studies. Fertil. Steril. 2014, 102, 192–198. [Google Scholar] [CrossRef] [PubMed]
  49. Gaitskell, K.; Green, J.; Pirie, K.; Reeves, G.; Beral, V.; Million Women Study Collaborators. Tubal ligation and ovarian cancer risk in a large cohort: Substantial variation by histological type. Int. J. Cancer 2016, 138, 1076–1084. [Google Scholar] [CrossRef] [PubMed]
  50. Miracle-McMahill, H.L.; Calle, E.E.; Kosinski, A.S.; Rodriguez, C.; Wingo, P.A.; Thun, M.J.; Heath, C.W., Jr. Tubal ligation and fatal ovarian cancer in a large prospective cohort study. Am. J. Epidemiol. 1997, 145, 349–357. [Google Scholar] [CrossRef] [PubMed]
  51. Ness, R.B. Endometriosis and ovarian cancer: Thoughts on shared pathophysiology. Am. J. Obstet. Gynecol. 2003, 189, 280–294. [Google Scholar] [CrossRef] [PubMed]
  52. De la Cuesta, R.S.; Eichhorn, J.H.; Rice, L.W.; Fuller, A.F., Jr.; Nikrui, N.; Goff, B.A. Histologic transformation of benign endometriosis to early epithelial ovarian cancer. Gynecol. Oncol. 1996, 60, 238–244. [Google Scholar] [CrossRef]
  53. Kato, N.; Sasou, S.; Motoyama, T. Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary. Mod. Pathol. 2006, 19, 83–89. [Google Scholar] [CrossRef] [PubMed]
  54. Dubeau, L. The cell of origin of ovarian epithelial tumours. Lancet Oncol. 2008, 9, 1191–1197. [Google Scholar] [CrossRef]
Figure 1. The process of study selection.
Figure 1. The process of study selection.
Ijerph 13 01138 g001
Figure 2. (A) The forest plot for the association between endometriosis and EOC; (B) The forest plot for the association between hysterectomy and EOC; (C) The forest plot for the association between tubal ligation and EOC.
Figure 2. (A) The forest plot for the association between endometriosis and EOC; (B) The forest plot for the association between hysterectomy and EOC; (C) The forest plot for the association between tubal ligation and EOC.
Ijerph 13 01138 g002aIjerph 13 01138 g002b
Table 1. Characteristics of 38 case-control publications in this meta-analyses.
Table 1. Characteristics of 38 case-control publications in this meta-analyses.
ReferenceAuthorsCountryGroupYearCaseControlRisk FactorsNOS Score
[5]Ness et al.USANorth America19997671367Endometriosis8
[6]Madsen et al.DenmarkEurope201413,241194,689Endometriosis8
[7]Collette et al.USANorth America2014194388Endometriosis7
[11]Baandrup et al.DenmarkEurope2013347150,576Endometriosis8
[14]Ruiz et al.USANorth America2016208224Endometriosis8
[18]Modugno et al.USANorth America200420982953Endometriosis8
[19]Nagle et al.AustraliaOceania20082321508Endometriosis8
[20]Rossing et al.USANorth America20088121313Endometriosis8
[21]Wu et al.USANorth America2009609688Endometriosis7
[22]Moorman et al.USANorth America20098571057Endometriosis6
[23]Bodmer et al.SwitzerlandEurope201116119710Endometriosis8
[24]Merritt et al.USANorth America201315712100Endometriosis7
[11]Baandrup et al.DenmarkEurope2013347150,576Hysterectomy8
[12]Le et al.CanadaNorth America2014607334Hysterectomy8
[14]Ruiz et al.USANorth America2016208224Hysterectomy8
[18]Modugno et al.USANorth America200420982953Hysterectomy8
[19]Nagle et al.AustraliaOceania20082321508Hysterectomy8
[22]Moorman et al.USANorth America20098571057Hysterectomy6
[24]Merritt et al.USANorth America201315712100Hysterectomy7
[25]Whittemore et al.USANorth America1988188539Hysterectomy7
[26]Hartge et al.USANorth America1988296343Hysterectomy6
[27]Booth et al.EnglandEurope1989235451Hysterectomy7
[28]Irwin et al.USANorth America19914944238Hysterectomy8
[29]Parazzini et al.SwizerlandEurope19939532758Hysterectomy7
[30]Cramer et al.USANorth America1995450454Hysterectomy7
[31]Rosenblatt et al.USANorth America19963932563Hysterectomy8
[32]Green et al.AustraliaOceania1997824855Hysterectomy7
[33]Wittenberg et al.The NetherlandsEurope1999322426Hysterectomy7
[34]Riman et al.SwedenEurope20026553899Hysterectomy8
[35]Chiaffarino et al.ItalyEurope200510312411Hysterectomy8
[36]Mills et al.USANorth America20052561122Hysterectomy7
[37]Risch et al.USANorth America2006490534Hysterectomy7
[38]Faber et al.DenmarkEurope20135541564Hysterectomy7
[39]Rice et al.USANorth America201322652333Hysterectomy8
[6]Madsen et al.DenmarkEurope201413,241194,689Tubal ligation8
[7]Collette et al.USANorth America2014194388Tubal ligation7
[9]Pike et al.USANorth America2004477660Tubal ligation7
[11]Baandrup et al.DenmarkEurope2013347150,576Tubal ligation8
[13] Huang et al.ChinaChina201517470,085Tubal ligation7
[14]Ruiz et al.USANorth America2016208224Tubal ligation8
[18]Modugno et al.USANorth America200420982953Tubal ligation8
[19]Nagle et al.AustraliaOceania20082321508Tubal ligation8
[21]Wu et al.USANorth America2009609688Tubal ligation7
[24]Merritt et al.USANorth America201315712100Tubal ligation7
[30]Cramer et al.USANorth America1995450454Tubal ligation7
[31]Rosenblatt et al.USANorth America19963932563Tubal ligation8
[33]Wittenberg et al.The NetherlandsEurope1999322426Tubal ligation7
[34]Riman et al.SwedenEurope20026553899Tubal ligation8
[37]Risch et al.USANorth America2006490534Tubal ligation7
[38]Faber et al.DenmarkEurope20135541564Tubal ligation7
[39]Rice et al.USANorth America201322652333Tubal ligation8
[40]Mori et al.JapanAsia198856112Tubal ligation8
[41]Purdie et al.AustraliaOceania1995824860Tubal ligation7
[42]Narod et al.CanadaNorth America2001232232Tubal ligation8
[43]Mills et al.USANorth America20042561122Tubal ligation7
[44]McGuire et al.USANorth America2004417568Tubal ligation7
[45]Moorman et al.USANorth America2008896967Tubal ligation7
[46]Grant et al.USANorth America20104951086Tubal ligation8
[47]Vitonis et al.USANorth America201110981363Tubal ligation8
Table 2. Stratified meta-analyses of the association between three risk factors and ovarian cancer.
Table 2. Stratified meta-analyses of the association between three risk factors and ovarian cancer.
Risk FactorsNOR95% CII2 (%)pE-T2
Endometriosis
All121.421.28–1.5720.40˂0.010.24
Area
North America71.421.27–1.600.00˂0.01
Europe41.281.12–1.470.00˂0.01
Oceania12.521.63–3.90--˂0.01
Hysterectomy
All220.970.81–1.1484.700.680.31
Area
North America131.000.93–1.0974.600.94
Europe70.970.86–1.1088.300.63
Oceania20.980.79–1.2197.400.84
Tubal ligation
All250.680.59–0.7990.50˂0.010.64
Area
Asia20.850.58–1.2471.800.06
North America160.680.64–0.7287.90˂0.01
Europe50.820.75–0.8977.30˂0.01
Oceania20.480.39–0.600.00˂0.81
Heterogeneity assumption was checked by I2; N, number of studies; E-T2, p-value of Egger’s test.

Share and Cite

MDPI and ACS Style

Wang, C.; Liang, Z.; Liu, X.; Zhang, Q.; Li, S. The Association between Endometriosis, Tubal Ligation, Hysterectomy and Epithelial Ovarian Cancer: Meta-Analyses. Int. J. Environ. Res. Public Health 2016, 13, 1138. https://doi.org/10.3390/ijerph13111138

AMA Style

Wang C, Liang Z, Liu X, Zhang Q, Li S. The Association between Endometriosis, Tubal Ligation, Hysterectomy and Epithelial Ovarian Cancer: Meta-Analyses. International Journal of Environmental Research and Public Health. 2016; 13(11):1138. https://doi.org/10.3390/ijerph13111138

Chicago/Turabian Style

Wang, Chunpeng, Zhenzhen Liang, Xin Liu, Qian Zhang, and Shuang Li. 2016. "The Association between Endometriosis, Tubal Ligation, Hysterectomy and Epithelial Ovarian Cancer: Meta-Analyses" International Journal of Environmental Research and Public Health 13, no. 11: 1138. https://doi.org/10.3390/ijerph13111138

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop